Medicare Part C and Part D Program Integrity
Guidance for the Center for Program Integrity (CPI) Investigations and Audits Group's (IAG) Division of Plan Oversight and Accountability (DPOA) is responsible for program integrity efforts focused on combatting Fraud, Waste and Abuse (FWA) in the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs. Information will be provided periodically to keep the Medicare Part C and Part D communities updated on DPOA's current initiatives.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: March 31, 2015
The Center for Program Integrity (CPI) Audits and Vulnerabilities Group (AVG), Division of Prescription Drug Audits (DPDA) is responsible for program integrity efforts focused on combatting fraud, waste, and abuse (FWA) in the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs. Information will be provided periodically to keep the Medicare Part C and Part D communities updated on DPDA's current initiatives.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.